Total Payments
$2,870
2024 Payments
$476.15
Companies
14
Transactions
70
Medicare Patients
2,397
Medicare Billing
$152,958
Payment Breakdown by Category
Food & Beverage$2,838 (98.9%)
Education$31.78 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,838 | 68 | 98.9% |
| Education | $31.78 | 2 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $913.83 | 12 | $0 (2024) |
| ABBVIE INC. | $534.86 | 18 | $0 (2023) |
| Novo Nordisk Inc | $252.64 | 3 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $212.55 | 17 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $187.63 | 6 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $144.36 | 2 | $0 (2023) |
| OptiNose US, Inc. | $124.92 | 1 | $0 (2021) |
| Myovant Sciences Inc. | $124.74 | 1 | $0 (2021) |
| Phathom Pharmaceuticals, Inc. | $124.74 | 1 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $116.59 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $476.15 | 5 | AstraZeneca Pharmaceuticals LP ($314.33) |
| 2023 | $561.57 | 11 | Sumitomo Pharma America, Inc. ($187.63) |
| 2022 | $541.89 | 23 | Sunovion Pharmaceuticals Inc. ($199.78) |
| 2021 | $1,290 | 31 | AbbVie Inc. ($394.39) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $126.22 | General |
| Category: Respiratory | ||||||
| 02/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 01/18/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $37.08 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 01/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $63.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/02/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $51.26 | General |
| Category: Respiratory | ||||||
| 10/23/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $123.48 | General |
| Category: HORMONE THERAPY | ||||||
| 09/21/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $44.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/13/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Education | In-kind items and services | $19.62 | General |
| Category: Cardio-renal | ||||||
| 06/02/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $9.69 | General |
| Category: UROLOGY | ||||||
| 05/10/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $133.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/25/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: UROLOGY | ||||||
| 03/30/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: UROLOGY | ||||||
| 03/07/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: UROLOGY | ||||||
| 02/16/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: UROLOGY | ||||||
| 02/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $14.33 | General |
| Category: PSYCHOLOGY | ||||||
| 11/23/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: UROLOGY | ||||||
| 11/10/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: UROLOGY | ||||||
| 10/19/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: UROLOGY | ||||||
| 10/13/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: UROLOGY | ||||||
| 10/11/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: UROLOGY | ||||||
| 09/15/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: UROLOGY | ||||||
| 09/14/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $35.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/30/2022 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 651 | 1,014 | $184,176 | $45,278 |
| 2022 | 17 | 623 | 980 | $171,038 | $43,031 |
| 2021 | 10 | 518 | 761 | $133,467 | $33,471 |
| 2020 | 12 | 605 | 906 | $146,106 | $31,178 |
Total Patients
2,397
Total Services
3,661
Medicare Billing
$152,958
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 261 | $79,743 | $17,042 | 21.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 64 | 64 | $21,105 | $6,647 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 110 | $22,801 | $5,267 | 23.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $12,900 | $3,385 | 26.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 44 | 45 | $11,395 | $3,086 | 27.1% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 20 | 20 | $7,940 | $2,441 | 30.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 120 | 216 | $3,299 | $1,814 | 55.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 53 | 54 | $4,874 | $1,517 | 31.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $5,220 | $1,438 | 27.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 44 | 84 | $6,143 | $773.57 | 12.6% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 20 | 20 | $1,580 | $725.23 | 45.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 63 | $4,421 | $479.11 | 10.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $1,080 | $343.56 | 31.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 13 | 13 | $1,092 | $256.68 | 23.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 24 | 29 | $583.00 | $62.17 | 10.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 129 | 299 | $91,195 | $20,354 | 22.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 51 | 51 | $16,779 | $5,390 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 68 | $14,076 | $3,358 | 23.9% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2022 | 21 | 22 | $9,416 | $3,102 | 32.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 37 | 38 | $8,695 | $2,595 | 29.8% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 13 | 15 | $6,930 | $1,983 | 28.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 46 | 48 | $4,160 | $1,311 | 31.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 11 | $4,532 | $1,287 | 28.4% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 22 | 22 | $1,122 | $795.52 | 70.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 43 | 68 | $4,964 | $651.63 | 13.1% |
About Traci Mccartney, APN
Traci Mccartney, APN is a Nurse Practitioner healthcare provider based in Clarksville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043275530.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Traci Mccartney, APN has received a total of $2,870 in payments from pharmaceutical and medical device companies, with $476.15 received in 2024. These payments were reported across 70 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,838).
As a Medicare-enrolled provider, Mccartney has provided services to 2,397 Medicare beneficiaries, totaling 3,661 services with total Medicare billing of $152,958. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Clarksville, IN
- Active Since 04/19/2006
- Last Updated 09/04/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1043275530
Products in Payments
- FARXIGA (Drug) $391.90
- VRAYLAR (Drug) $275.61
- BREZTRI (Drug) $270.71
- GEMTESA (Drug) $263.93
- UBRELVY (Drug) $259.25
- AIRSUPRA (Drug) $251.22
- MYFEMBREE (Drug) $248.22
- Ozempic (Drug) $245.00
- Kerendia (Drug) $144.36
- Xhance (Drug) $124.92
- VOQUEZNA (Drug) $124.74
- NURTEC ODT (Drug) $116.59
- LEQVIO (Drug) $44.18
- Qelbree (Drug) $37.08
- Aimovig (Biological) $25.22
- QELBREE (Drug) $14.33
- APTIOM (Drug) $12.77
- Trudhesa (Drug) $12.16
- RYBELSUS (Drug) $7.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Clarksville
Brittany Graham, Fnp-C, FNP-C
Nurse Practitioner — Payments: $5,846
Nurse Practitioner $5,846
Julia Doss, Aprn, APRN
Nurse Practitioner — Payments: $2,828
Nurse Practitioner $2,828
Deana Hooton, Np, NP
Nurse Practitioner — Payments: $2,620
Nurse Practitioner $2,620
Louisa Jones, Np, NP
Nurse Practitioner — Payments: $2,613
Nurse Practitioner $2,613
Jodie Ward, Apn, APN
Nurse Practitioner — Payments: $2,572
Nurse Practitioner $2,572
Clara Weaver
Nurse Practitioner — Payments: $2,247
Nurse Practitioner $2,247